Page 258 - Multidisipliner Covid 19
P. 258

BÖLÜM  14






             Gómez R, Arévalo-Villalobos JI. What does plant-based vaccine tech-
             nology offer to the fight against COVID-19? Vaccines. 2020;8(2). doi:10.
             3390/vaccines8020183
         24.  Pogrebnyak N, Golovkin M, Andrianov V, et al. Severe Acute Respiratory
             Syndrome (SARS) S Protein Production in Plants: Development of Recom-
             binant Vaccine.; 2005. www.pnas.orgcgidoi10.1073pnas.0503760102.
             Accessed June 3, 2020.
         25.  Muthumani K, Falzarano D, Reuschel EL, et al. A synthetic consensus
             anti-spike protein DNA vaccine induces protective immunity against
             Middle East respiratory syndrome coronavirus in nonhuman primates.
             Sci Transl Med. 2015;7(301):301ra132-301ra132. doi:10.1126/scitranslmed.
             aac7462
         26. Wrapp D, Wang N, Corbett KS, et al. Cryo-EM Structure of the 2019-
             NCoV Spike in the Prefusion Conformation.; 2019. http://science.sci-
             encemag.org/.
         27.  Jiang S, Elena Bottazzi M, Du L, et al. Roadmap to developing a recom-
             binant coronavirus S protein receptor-binding domain vaccine for
             severe acute respiratory syndrome. Expert Rev Vaccines. 2012;11(12):
             1405-1413. doi:10.1586/erv.12.126
         28.  Bhattacharya M, Sharma AR, Patra P, et al. Development of epitope_
             based peptide vaccine against novel coronavirus 2019 (SARS-COV-2):
             Immunoinformatics approach. J Med Virol. 2020;92(6):618-631. doi:10.
             1002/jmv.25736
         29. Dr. Seema M. T Cell Epitope-Based Vaccine Design for Pandemic Novel
             Coronavirus 2019-nCoV. chemRxiv. 2020. doi:10.26434/chemrxiv.
             12029523.v2
         30.  Yu J, Tostanoski LH, Peter L, et al. DNA vaccine protection against
             SARS-CoV-2 in rhesus macaques. Science (80- ). May 2020:eabc6284.
             doi:10.1126/science.abc6284
         31.  Koyama T, Weeraratne D, Snowdon JL, Parida L. Emergence of Drift
             Variants That May Affect COVID-19 Vaccine Development and Anti-
             body Treatment. Pathogens. 2020;9(5):324. doi:10.3390/pathogens9050324
         32.  Thanh Le T, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine
             development landscape. Nat Rev Drug Discov. 2020;19(5):305-306. doi:
             10.1038/d41573-020-00073-5
         33.  Tseng C Te, Sbrana E, Iwata-Yoshikawa N, et al. Immunization with
             SARS coronavirus vaccines leads to pulmonary immunopathology on




                                                                        257
   253   254   255   256   257   258   259   260   261   262   263